Letrozole co-treatment in an antagonist protocol for overweight women undergoing IVF treatment: a retrospective study
Abstract Background Overweight women undergoing IVF treatment have lower success rates. Letrozole, an aromatase inhibitor, has been used as an adjunct for IVF treatment, but its specific effects in overweight women have not been investigated. This study was to explore the effects of letrozole co-tre...
Saved in:
Main Authors: | Jing Lin (Author), Fenglu Wu (Author), Yanwen Zhu (Author), Bian Wang (Author), Zhengjun Cao (Author), Jiaying Lin (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of letrozole co-treatment in an antagonist protocol for IVF/ICSI: a retrospective study
by: Jing Lin, et al.
Published: (2024) -
The Efficacy of Letrozole Co-Treatment in an Antagonist Protocol for Women with Polycystic Ovary Syndrome Undergoing IVF: A Retrospective Study
by: Lin J, et al.
Published: (2024) -
Comparison of an estradiol patch and GnRH-antagonist protocol with a letrozole/antagonist protocol for patients without oocyte development, fertilization and/or embryo development in previous IVF cycles
by: Aybike Pekin, et al.
Published: (2021) -
Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial
by: Ashraf Moini, et al.
Published: (2019) -
Letrozole+ GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: An RCT
by: Mahbod Ebrahimi, et al.
Published: (2017)